Recently, the Zhengzhou Municipal Bureau of Industry and Information Technology announced the list of Zhengzhou Enterprise Technology Centers for 2023, and Leadingpharm-Deep Blue Ocean (Zhengzhou) was successfully selected. This is another honor after being awarded honors such as High tech Enterprise, Specialized and New Small and Medium sized Enterprise of Henan, Zhengzhou Specialized and New Small & Medium sized Enterprise, and Zhengzhou MAH Platform and Liquid Formulation Engineering Research Center.
 

Deep Blue Ocean currently has over 50 varieties under research, covering oral solid preparations such as tablets, capsules, granules, orally disintegrating tablets, suspensions, enteric coated preparations, as well as sterile powder injections, oral liquids, freeze-dried preparations, injections, emulsions and other liquid preparations, involving anti-tumor, anti allergic, antibiotic, cardiovascular, cerebrovascular, neurological and other fields.
 

This recognition is a comprehensive recognition by the Zhengzhou Municipal Bureau of Industry and Information Technology of Deep Blue Ocean's innovation capability, innovative talents, technological accumulation, and research and development investment. In the future, Deep Blue Ocean will continue to improve its independent innovation capabilities, strive to break through core technological issues in the field of pharmaceutical research and development, promote industrial development, and contribute to the Healthy China Strategy.